Introducing India's First Rapid Point Of Care Test For Preeclampsia Assessment

The Lumella™ Test System

About Us

Diabetomics, Inc.

Diabetomics, Inc. is a global, commercial stage medical diagnostics company pioneering innovative, non-invasive point-of-care tests that are especially useful in alleviating the substantial economic and public health burden of maternal health and diabetes.

Diabetomics Medical Pvt Ltd

Diabetomics Medical Pvt Ltd, Hyderabad, India.

LEARN MORE

Diabetomics Health Sciences

The sales and marketing division of Diabetomics Inc., (USA). The Lumella Preeclampsia test is now available in many cities through our sales team and authorized distributors.

LAUNCHMATERIALSEVENTS
WHAT WE OFFER

Rapid Point Of Care Tests

The first in a series of products launched is the Lumella Test system for Preeclampsia

Lumella™ Available Now

The first and only point-of-care tests for early detection of preeclampsia.

Glucema™ Coming Soon

The first and only point-of-care saliva test for diabetes monitoring.

Insudex™ Coming Soon

The first and only point-of-care tests for early detection of type-1 diabetes and LADA (Latent Autoimmune Diabetes in Adults).

CONNECT WITH US

Contact us

We would like to hear from you.